TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Institutional Trading Activity
TEVA PHARMACEUTICAL-SP ADR (TEVA) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q3 2025), investors with some of the largest reported share count changes include Viking Global Investors, Renaissance Technologies LLC, Sound Shore Management, Sequoia Financial Advisors, and ARK Invest. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.
Explore more:
- TEVA PHARMACEUTICAL-SP ADR (TEVA) stock institutional ownership
- TEVA PHARMACEUTICAL-SP ADR (TEVA) stock insider trading activity
- Stock rankings
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q3 2014 | Renaissance Technologies LLC | Sell | -239,800 | 264,863 | $14,236 |
| Q3 2014 | First Eagle U.S. Value | Buy | 1,420,380 | 1,420,580 | $76,356 |
| Q3 2014 | Matrix Advisors Value Fund | Sell | -1,710 | 363,462 | $19,536 |
| Q2 2014 | Muhlenkamp & Co | Buy | 1,415 | 176,855 | $9,271 |
| Q2 2014 | Renaissance Technologies LLC | Buy | 206,300 | 504,663 | $26,454 |
| Q2 2014 | Matrix Advisors Value Fund | Sell | -5,305 | 365,172 | $19,142 |
| Q1 2014 | Muhlenkamp & Co | Sell | -900 | 175,440 | $9,270 |
| Q1 2014 | Matrix Advisors Value Fund | Sell | -54,984 | 370,477 | $19,576 |
| Q4 2013 | Muhlenkamp & Co | Buy | 6,355 | 176,340 | $7,068 |
| Q4 2013 | Matrix Advisors Value Fund | Sell | -25,153 | 425,461 | $17,052 |
| Q3 2013 | Muhlenkamp & Co | Buy | 325 | 169,985 | $6,422 |
| Q3 2013 | Matrix Advisors Value Fund | Buy | 5,355 | 450,614 | $17,024 |
| Q2 2013 | Muhlenkamp & Co | Buy | 169,660 | 169,660 | $6,651 |
| Q2 2013 | Eagle Capital Management | Buy | 22,400 | 22,400 | $878 |
| Q2 2013 | First Eagle U.S. Value | Buy | 200 | 200 | $8 |
| Q2 2013 | Renaissance Technologies LLC | Buy | 298,363 | 298,363 | $11,696 |
| Q2 2013 | Abrams Capital Management | Buy | 2,561,269 | 2,561,269 | $100,402 |
| Q2 2013 | Matrix Advisors Value Fund | Buy | 445,259 | 445,259 | $17,454 |
Frequently asked questions about TEVA activity
Which institutional owners are buying TEVA?
Institutional owners buying TEVA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in TEVA activity?
"Buy" means an investor increased their reported position in TEVA compared to the prior reporting period. This reflects growing exposure to TEVA PHARMACEUTICAL-SP ADR (TEVA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in TEVA increasing?
Institutional interest in TEVA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.